Rheumatoid Arthritis Drugs for Schizophrenia?. Buckley, P. F. & Miller, B. J. Psychiatric Annals, 48(5):232–236, May, 2018. ZSCC: 0000001 Publisher: SLACK Incorporated
Rheumatoid Arthritis Drugs for Schizophrenia? [link]Paper  doi  abstract   bibtex   
Psychiatric Annals \textbar Any relationship between treatment of rheumatoid arthritis and the current treatment of schizophrenia seems, at first glance, far-fetched. And yet, in a relatively short period of intensive research work, the field of schizophrenia research has come to appreciate that there are fundamental immunological associations with schizophrenia. Several groups have conducted studies of antirheumatic
@article{buckley_rheumatoid_2018,
	title = {Rheumatoid {Arthritis} {Drugs} for {Schizophrenia}?},
	volume = {48},
	issn = {0048-5713, 1938-2456},
	url = {https://www.healio.com/psychiatry/journals/psycann/2018-5-48-5/{4a1c3326-1508-4ca0-9577-146258e785bb}/rheumatoid-arthritis-drugs-for-schizophrenia},
	doi = {10.3928/00485713-20180405-01},
	abstract = {Psychiatric Annals {\textbar} Any relationship between treatment of rheumatoid arthritis and the current treatment of schizophrenia seems, at first glance, far-fetched. And yet, in a relatively short period of intensive research work, the field of schizophrenia research has come to appreciate that there are fundamental immunological associations with schizophrenia. Several groups have conducted studies of antirheumatic},
	language = {en},
	number = {5},
	urldate = {2020-08-13},
	journal = {Psychiatric Annals},
	author = {Buckley, Peter F. and Miller, Brian J.},
	month = may,
	year = {2018},
	note = {ZSCC: 0000001 
Publisher: SLACK Incorporated},
	pages = {232--236},
}

Downloads: 0